Obesity

WHO issues first guidelines backing GLP-1 drugs for obesity management

WHO has issued its first guidelines recommending GLP-1 drugs for long-term obesity treatment in adults, while stressing equitable access, health system readiness and lifestyle support

Metropolis launches GLP-1 monitoring test packages, targets obesity market

Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment

Why alcohol may hit harder for people on GLP-1 drugs like Ozempic, Wegovy

A Yale study suggests GLP-1 drugs like semaglutide slow alcohol breakdown in the liver, raising blood alcohol levels even as they reduce toxic byproducts linked to inflammation and liver damage

Biorad Medisys works on 'pacemaker' for managing diabetes with VNS tech

Pune-based Biorad Medisys is developing an implantable vagus nerve stimulation device that aims to improve insulin balance, regulate hunger, and support obesity care without drugs or chemical compound

Why losing weight is harder than we think, and how evolution has shaped it

Advances in obesity and metabolism research may mean that future therapies can be able to turn down these signals that drive the body back to its original weight, even beyond the treatment period

Did you gain weight in first year of college? Here's the science behind it

A new study finds that college students often misjudge how much they eat, especially in dining halls or social settings, highlighting how environment drives calorie intake and weight gain

Russian teens turn to Molecule, a banned pill with deadly weight-loss risks

Marketed as a herbal weight-loss supplement, Molecule has gone viral on Russian TikTok but contains a banned drug linked to heart attacks, anxiety, and hospitalisations among teenagers

Study finds obesity-related cancer cases increasing in young, older adults

Cancer cases linked with obesity, previously observed as rising among the youth, could also be increasing in both young and older adults worldwide, according to a global analysis. Researchers from The Institute of Cancer Research and Imperial College London cautioned that new studies focusing solely on younger adults for rise in cancer cases should be carefully considered. The study, published in the journal Annals of Internal Medicine, which examined annual cancer incidence from 2003 to 2017 found that five obesity-related cancers -- thyroid, breast, kidney, endometrial, and blood (leukaemia) -- have risen in both adults aged 2049 and those 50 and older. All the five cancers are related to obesity, the team said. The data from 42 countries across Asia, Europe, Africa, North and South America, and Australasia drawn from the International Agency for Research on Cancer's 'GLOBOCAN' database was analysed. Rates of cancer incidence were found to have increased among younger adults in

Food addiction: Snacks could trigger the brain like drugs, study shows

Multiple studies have also found that suddenly ending a diet that's high in sugar can cause withdrawal, similar to when people quit opioids or nicotine

Vasundhara Raje urges united effort to tackle global obesity crisis

Former chief minister Vasundhara Raje called for collective efforts to combat obesity. She said, "Many people appear thin on the outside, but they have internal fat, which is more dangerous." Raje, while speaking at a programme, said obesity is becoming an epidemic worldwide and that the effort to curb it should not be the responsibility of politicians alone, but of everyone. She mentioned that she ensures her weight does not increase and follows regular exercise, intermittent fasting, etc., to maintain her health. She also stated that over a billion people worldwide suffer from obesity. "Losing weight is not the end goal but the beginning of a healthy and energetic life," she said. Raje highlighted that nearly 15 per cent of children in India are overweight, making it necessary to educate children about proper nutrition, similar to the practices in Japan.

Body fat may secretly fuel Alzheimer's disease, finds new research

New research from Houston Methodist reveals how obesity may directly drive Alzheimer's disease.Scientists discovered that tiny messengers released by fat tissue, called extracellular vesicles, can carry harmful signals that accelerate the buildup of amyloid-b plaques in the brain.These vesicles even cross the blood-brain barrier, making them powerful but dangerous connectors between body fat and brain health.The study, "Decoding Adipose-Brain Crosstalk: Distinct Lipid Cargo in Human Adipose-Derived Extracellular Vesicles Modulates Amyloid Aggregation in Alzheimer's Disease," was published on October 2 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.It explores the link between obesity, which affects about 40% of the U.S population, and the dreaded neurodegenerative disease affecting more than 7 million people in the U.S.The research was led by Stephen Wong, Ph.D., the John S. Dunn Presidential Distinguished Chair in Biomedical Engineering .Alongside Wong, ..

All carbs, little protein: How rice, roti, sugar are hurting India's health

ICMR survey shows 62 per cent of Indian calories come from carbs, linking rice, roti and sugar to rising diabetes, obesity and why adding more protein could reverse the trend

Liver fat, not bodyweight, predicts health risks in obese children: Study

Children with "unhealthy obesity" were three times more likely born from high-risk pregnancies, linking early-life factors to later metabolic health risks

What happens to your body when you eat too many ultra-processed foods

researchers found that individuals in the highest UPF intake group (60 per cent to 79 per cent of daily calories) had an 11 per cent higher likelihood of elevated hs-CRP levels

After Mounjaro success, Eli Lilly plans to launch weight-loss pill in India

Unlike injectable Mounjaro, which focuses on patients with a BMI above 35, Orforglipron is designed for the larger group of patients with a BMI of 27-34, offering an expected weight reduction of 12-16

Scientists test 4-in-1 drug that may rival Ozempic and bariatric surgery

Researchers explore next-gen obesity drug targeting four hormones at once to overcome limits of existing treatments

Will this court fight make the world's hottest weight-loss drug cheaper?

Indian pharma takes Novo Nordisk to court over patents that keep Wegovy and Ozempic out of reach - could this slash prices for millions of patients?

From stomach paralysis to vision loss: Ozempic faces over $2 bn lawsuits

Ozempic, the viral weight-loss injection, is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, vision loss, and lasting health damage

Ozempic, other weight-loss drugs tied to rare, serious eye issue: Study

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood flow to the optic nerve is suddenly reduced or blocked

Cult Fit co-founder's realistic weight loss lessons for lasting results

From better sleep to mindful hydration, Cult Fit co-founder Rishabh Telang shares six simple, science-backed weight loss tips that fit into real life, no crash diets required